Journal
JOURNAL OF NANOPARTICLE RESEARCH
Volume 17, Issue 3, Pages -Publisher
SPRINGER
DOI: 10.1007/s11051-015-2938-0
Keywords
PET; F-18-SFB; Labelling; Mesoporous silica nanoparticles; Biodistribution; Mice; Biomedical
Categories
Funding
- Carlos III Health Institute [CP13/00252, CP10/036]
- Spanish Ministry of Economy and Competitiveness [CTQ2012- 32315]
- Generalitat Valenciana
- CDTI
- CENIT Programme
- Spanish Ministry of Science and Innovation
Ask authors/readers for more resources
Nanoparticles have been proposed for several biomedical applications due to their potential as drug carriers, diagnostic and therapeutic agents. However, only a few of them have been approved for their use in humans. In order to gauge the potential applicability of a specific type of nanoparticle, in vivo biodistribution studies to characterize their pharmacokinetic properties are essential. In this regard, mesoporous silica nanoparticles (30-130 nm) have been functionalized with amino groups in order to react with N-succinimidyl 4-[F-18]fluorobenzoate and thus anchor the F-18 positron emission isotope by using a novel and easy labelling strategy. In vivo biodistribution was characterized in mice after intravenous administration of radiolabelled nanoparticles by positron emission tomography. Our results indicated that radiolabelled mesoporous silica nanoparticles were excreted into bile and urine and accumulated mainly in the organs of the reticuloendothelial system and lungs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available